The fairest thing to say about CBT is not that it is the best therapy for everything, but that it is a genuinely effective therapy for a great many things, with better long-term durability than most, and honest researchers about its limits.
CBT produces reliable, moderate-to-large improvements over no treatment for anxiety and depression, and its benefits tend to be durable after therapy ends. It works about as well as medication for many anxiety disorders and mild-to-moderate depression, with lower relapse than stopping drugs. But it is not universal: a meaningful minority do not respond, dropout runs in the region of one in five, it works best for people who engage with its structured, active style, and there is genuine debate over whether it truly beats other well-delivered therapies. The right summary is effective and durable, not miraculous or universal.
How effectiveness is measured
To read claims about how well CBT works, you need to know what the numbers are measuring and against what. The strength of a result depends heavily on the comparison group, and this is where a lot of confusion begins.
Versus waitlist or no treatment
The easiest bar to clear. Here CBT shows large effects, but waitlist comparisons systematically overstate benefit, because being on a waitlist can be worse than getting any attention at all. Impressive-looking effect sizes against waitlist should be read with caution.
Versus placebo or active control
A tougher, fairer test that controls for attention and expectation. Effects shrink compared with waitlist comparisons but generally remain meaningful, especially for anxiety disorders. This is a more honest measure of what the specific therapy adds.
Versus medication
For many anxiety disorders and mild-to-moderate depression, CBT performs roughly on par with medication in the short term, and often better in the long term because its gains persist after treatment ends. For severe depression, combining the two frequently beats either alone.
Versus other therapies
The most contested comparison. When CBT is set against other well-structured, bona fide therapies, differences often shrink or disappear, which is the heart of the dodo bird debate discussed below.
A single effect size means little without knowing which of these comparisons produced it. Much of the gap between CBT's most enthusiastic and most sceptical portrayals comes down to which comparison the writer chose to feature.
Some representative figures
Treat these as well-supported approximations rather than exact constants. They vary with condition, population, and how outcome is defined, but they convey the general scale of the effect.
The genuine strengths
Set against fair comparisons, three strengths of CBT stand out as well supported rather than promotional.
The honest limits
A balanced account has to give equal weight to where CBT falls short. None of these limits means it does not work; they mean it does not work for everyone or every problem.
Non-response
A substantial minority of people do not improve meaningfully with CBT, even when it is delivered well. Response is far from guaranteed, and for those who do not respond, switching approach or combining treatments is often the sensible next step rather than repeating the same protocol.
Dropout
Roughly one in five people leave before completing a course, though this varies widely by condition and setting. The structured, homework-based demands that make CBT effective for engaged clients can be a poor fit for others, and dropout selectively removes some who might not have benefited anyway, which can flatter completer-only results.
Fit and preference
CBT suits people willing to take an active, present-focused, practice-heavy approach. Those who want to explore their history in depth, or who value the relationship itself as the vehicle of change, may engage better with a different therapy. Client preference genuinely predicts outcome.
Delivery quality
Results depend heavily on a competent therapist delivering a proper, condition-specific protocol, and on the client doing the between-session work. Watered-down or generic CBT, or CBT without homework, tends to underperform, so real-world outcomes can fall short of trial conditions.
The dodo bird debate
No discussion of CBT's effectiveness is complete without the question that unsettles the whole field: does CBT really beat other good therapies, or do they all work about equally well?
The dodo bird verdict, named after the Alice in Wonderland character who declares that everyone has won, is the finding that when bona fide therapies are compared head to head, differences between them often shrink or vanish. On this view, what drives improvement is largely the common factors shared by all good therapies, a strong alliance, a credible rationale, and an engaged client, rather than the specific techniques CBT prides itself on. CBT advocates counter that for some conditions, notably OCD, phobias, and PTSD, specific techniques like exposure clearly outperform therapies that lack them, so the verdict does not hold everywhere. The fair position is that common factors matter enormously and that specific techniques matter more for some conditions than others. CBT's real distinction may be less that it is uniquely powerful and more that it is well specified, teachable, testable, and durable.
A myth to retire
The confident gold-standard framing produces one particularly common overstatement.
CBT is proven to be the most effective therapy, so it is the best choice for everyone.
CBT is genuinely effective and exceptionally well studied, but best for everyone is a step too far. Against other well-delivered therapies its advantage often narrows, a meaningful minority do not respond, and preference and fit strongly shape outcomes. The accurate claim is that CBT is a strong, durable, first-line option for many people and conditions, not that it is superior for all of them.
Where to go next
This page has weighed the outcomes. The research page steps back to sort which of these claims are settled, which are still moving, and which remain genuinely contested.
Sources
- Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clinical Psychology Review. 2006;26:17-31.
- Cuijpers P, Karyotaki E, Weitz E, Andersson G, Hollon SD, van Straten A. The effects of psychotherapies for major depression in adults on remission, recovery and improvement: A meta-analysis. Journal of Affective Disorders. 2014;159:118-126.
- Hofmann SG, Asnaani A, Vonk IJJ, Sawyer AT, Fang A. The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses. Cognitive Therapy and Research. 2012;36:427-440.
This page is educational and is not medical advice. It does not diagnose any condition or replace treatment. Effectiveness varies by person and condition. If you are struggling, speak with a qualified professional about which treatment is likely to suit you.